Litcius/Paper detail

HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis

Shaina F. Bruce, Sharon Wu, Jennifer R. Ribeiro, Alex Farrell, Matthew J. Oberley, Ira Winer, Britt Erickson, Tenley Klc, Nathaniel Jones, Premal H. Thaker, Matthew A. Powell

2023Gynecologic Oncology13 citationsDOI

Topics & Concepts

MedicineEndometrial cancerImmune systemCancerTumor microenvironmentCancer researchOncologyImmunologyInternal medicineEndometrial and Cervical Cancer TreatmentsHER2/EGFR in Cancer ResearchFerroptosis and cancer prognosis
HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis | Litcius